Vandria
Small molecule mitophagy inducers developer to treat age-related and chronic diseases.
2
Funding Rounds
$51.7m
Money raised
Overview
Small molecule mitophagy inducers developer to treat age-related and chronic diseases.
- Website:
- Headquarters: Lausanne
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Vandria has raised a total of $21m in funding over 2 rounds.
Key Insights:
- Vandria December 2023 Series A Funding Round: $21m
- Vandria Series A Round, August 2024: $30.7m
Vandria December 2023 Series A Funding Round
$21m
Vandria Series A Round, August 2024
$30.7m
Industries
Vandria is active in the following industries:
- Health technology
- Biotechnology